A synthetic microbial consortium to detect and kill Vibrio cholerae

2018 ◽  
Author(s):  
Margaux Cescato ◽  
Leila Dumas ◽  
Leo Gerlin ◽  
Marie Grandjean ◽  
Teo Hebra ◽  
...  

Vibrio cholerae is nowadays still problematic in several countries which are exposed to recurrent disease outbreaks. The current disease detection and treatment methods are efficient so this approach focused on the prevention of the disease. Indeed, current solutions are not efficient enough to deal with this situation. As V. cholerae which infects more than a million people each year is usually found in water, a synthetic microbial consortium was designed to detect and kill efficiently the bacteria in water. This work shows that Vibrio harveyi, a non-pathogenic strain to human, can be an efficient detector of V. cholerae. Moreover, it proves that Pichia pastoris, a yeast, can efficiently produce a novel antimicrobial peptide coming from the crocodile Crocodylus siamensis (i.e D-NY15) and that this peptide has a killing action towards V. cholerae. This study also shows that a communication between a prokaryote (Vibrio harveyi) and an eukaryote (Pichia pastoris) may be possible.

RSC Advances ◽  
2015 ◽  
Vol 5 (120) ◽  
pp. 99228-99239 ◽  
Author(s):  
Priyanka A. Bedekar ◽  
Siddheshwar D. Kshirsagar ◽  
Avinash R. Gholave ◽  
Sanjay P. Govindwar

Combinatorial adsorption–biodegradation treatment of textile wastewater provides a cost effective and ecofriendly alternative to conventional physicochemical treatment methods.


Pathogens ◽  
2020 ◽  
Vol 9 (12) ◽  
pp. 1051
Author(s):  
Gerald N. Misol ◽  
Constantina Kokkari ◽  
Pantelis Katharios

Vibrio harveyi is a Gram-negative marine bacterium that causes major disease outbreaks and economic losses in aquaculture. Phage therapy has been considered as a potential alternative to antibiotics however, candidate bacteriophages require comprehensive characterization for a safe and practical phage therapy. In this work, a lytic novel jumbo bacteriophage, vB_VhaM_pir03 belonging to the Myoviridae family was isolated and characterized against V. harveyi type strain DSM19623. It had broad host lytic activity against 31 antibiotic-resistant strains of V. harveyi, V. alginolyticus, V. campbellii and V. owensii. Adsorption time of vB_VhaM_pir03 was determined at 6 min while the latent-phase was at 40 min and burst-size at 75 pfu/mL. vB_VhaM_pir03 was able to lyse several host strains at multiplicity-of-infections (MOI) 0.1 to 10. The genome of vB_VhaM_pir03 consists of 286,284 base pairs with 334 predicted open reading frames (ORFs). No virulence, antibiotic resistance, integrase encoding genes and transducing potential were detected. Phylogenetic and phylogenomic analysis showed that vB_VhaM_pir03 is a novel bacteriophage displaying the highest similarity to another jumbo phage, vB_BONAISHI infecting Vibrio coralliilyticus. Experimental phage therapy trial using brine shrimp, Artemia salina infected with V. harveyi demonstrated that vB_VhaM_pir03 was able to significantly reduce mortality 24 h post infection when administered at MOI 0.1 which suggests that it can be an excellent candidate for phage therapy.


2018 ◽  
Vol 2 (1) ◽  
pp. 23-29 ◽  
Author(s):  
Zeqiang Liu ◽  
Mingxing Zhu ◽  
Xiangjun Chen ◽  
Guimao Yang ◽  
Tiantian Yang ◽  
...  

2008 ◽  
Vol 43 (10) ◽  
pp. 1124-1131 ◽  
Author(s):  
Lei Wang ◽  
Chun-e Lai ◽  
Qifeng Wu ◽  
Junliang Liu ◽  
Maojun Zhou ◽  
...  

Author(s):  
Robert J. Kosinski

AbstractA series of spreadsheet simulations using SEIS, SEIR, and SEIRS models showed that different durations of effective immunity could have important consequences for the prevalence of an epidemic disease with COVID-19 characteristics. Immunity that lasted four weeks, twelve weeks, six months, one year, and two years was tested with pathogen R0 values of 1.5, 2.3, and 3.0. Shorter durations of immunity resulted in oscillations in disease prevalence. Immunity that lasted from three months to two years produced recurrent disease outbreaks triggered by the expiration of immunity. If immunity “faded out” gradually instead of persisting at full effectiveness to the end of the immune period, the recurrent outbreaks became more frequent. The duration of effective immunity is an important consideration in the epidemiology of a disease like COVID-19.


Sign in / Sign up

Export Citation Format

Share Document